Abstract
Most animal models of sensorineural hearing loss show either selective outer hair cell (OHC) loss, or combined OHC and inner hair cell (IHC) loss. Several years ago, Robert Harrison and colleagues discovered that carboplatin could produce a selective IHC loss in the chinchilla. Carboplatin is a second-generation, platinum-based anti-neoplastic agent. In chinchillas, the effect of carboplatin administered systemically is dose dependent, and for the appropriate dosage, produces selective, patchy IHC loss that extends the length of the cochlea. As the vast majority of auditory-nerve afferents innervate the IHCs, this patchy IHC loss due to carboplatin leads to a partial deafferentation of the cochlea. This invited presentation will review a series of studies investigating near-field auditory evoked potentials in the chinchilla that have been performed at the University at Buffalo by the author and his colleagues. Chronic electrode implantation combined with passive animal restraint allow us to record from unanesthetized animals, thus avoiding the confounding effects of anesthesia. Responses from multiple levels of the nervous system (e.g., round window, auditory nerve, inferior colliculus, auditory cortex) will be reported, comparing responses before and after inducing partial IHC loss. [Work supported by NIH NICDC DC03600.]
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
